IONS vs MCD · rev $226.6M vs P/E 23, rev $25.92B
Ionis Pharmaceuticals Inc (IONS) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
IONS currently screens at market cap $12.28B. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the IONS and MCD stock pages for the full models.
Not investment advice.